Nuvig Therapeutics is based in Palo Alto, California. It has raised $208M in total funding. Latest round: Series B.
Nuvig Therapeutics is based in Palo Alto, California. Nuvig Therapeutics has raised $208M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for Nuvig Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital, Sanofi Ventures and 7 others. 13 distinct backers are named across the disclosed rounds.
Every Nuvig Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Palo Alto at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026